Literature DB >> 2606175

Prevalence of hepatitis B infection among hospital personnel in Addis Ababa (Ethiopia).

H Kefenie1, B Desta, A Abebe, S Conti, P Pasquini.   

Abstract

Hepatitis B serological markers (HBsAG, anti-HBc and anti-HBs) were determined in 432 (60%) hospital employees by the Hepanostika microenzyme linked immunoassay method. The overall prevalence rate was 9.02% for HBsAg, 46.25% for anti-HBs, 73.6% for anti-HBc and 76.38% for "at least one marker positive". Marker positivity as well as HBsAg carrier rate is higher for males than for females. (82.0 Vs 69.9%; 11.4 Vs 6.75% respectively). The majority of the infections occur early in life, 75% being positive for "at least one marker" by age twenty. The distribution of markers is somewhat different from previous observations with non-hospital personnel. Departments most exposed to blood and certain job categories seem to be an increased risk of acquiring the infection. We conclude that hospital exposure is associated with an additional risk of hepatitis B infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2606175     DOI: 10.1007/bf00140142

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  14 in total

1.  Homologous serum jaundice; an occupational hazard to medical personnel.

Authors:  M L TRUMBULL; D J GREINER
Journal:  J Am Med Assoc       Date:  1951-03-31

2.  Viral hepatitis: an occupational hazard to surgeons.

Authors:  J L Rosenberg; D P Jones; L R Lipitz; J B Kirsner
Journal:  JAMA       Date:  1973-01-22       Impact factor: 56.272

3.  The role of hepatitis virus A and B in jaundice in south Ethiopia.

Authors:  T H Henriksen
Journal:  Ethiop Med J       Date:  1984-01

4.  Viral hepatitis: an occupational hazard of medical personnel. Experience of the Yalenew Haven Hospital, 1952 to 1965.

Authors:  E B Byrne
Journal:  JAMA       Date:  1966-01-31       Impact factor: 56.272

5.  Epidemiology of hepatitis B in hospital personnel.

Authors:  C P Pattison; J E Maynard; D R Berquist; H M Webster
Journal:  Am J Epidemiol       Date:  1975-01       Impact factor: 4.897

6.  Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens.

Authors:  S C Hadler; B L Murphy; C A Schable; W L Heyward; D P Francis; M A Kane
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

7.  Hepatitis B in two Italian General Hospitals.

Authors:  P Pasquini; H A Kahn; D Pileggi; D Menichella; R Maddaluno; L Perroni; A Panà; E Guzzanti
Journal:  Boll Ist Sieroter Milan       Date:  1983-09-30

8.  Hepatitis A, B, and delta infection in Ethiopia: a serologic survey with demographic data.

Authors:  E Tsega; B Mengesha; B G Hansson; J Lindberg; E Nordenfelt
Journal:  Am J Epidemiol       Date:  1986-02       Impact factor: 4.897

9.  Hepatitis B virus infection in homes for the aged.

Authors:  M Chiaramonte; A Floreani; R Naccarato
Journal:  J Med Virol       Date:  1982       Impact factor: 2.327

10.  Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization?

Authors:  J L Dienstag; D M Ryan
Journal:  Am J Epidemiol       Date:  1982-01       Impact factor: 4.897

View more
  3 in total

1.  Seroprevalence of hepatitis B and C viruses among medical waste handlers at Gondar town Health institutions, Northwest Ethiopia.

Authors:  Belay Anagaw; Yitayal Shiferaw; Berhanu Anagaw; Yeshambel Belyhun; Woldearegay Erku; Fantahun Biadgelegn; Beyene Moges; Agersew Alemu; Feleke Moges; Andargachew Mulu
Journal:  BMC Res Notes       Date:  2012-01-22

2.  Hepatitis viruses in Ethiopia: a systematic review and meta-analysis.

Authors:  Yeshambel Belyhun; Melanie Maier; Andargachew Mulu; Ermias Diro; Uwe Gerd Liebert
Journal:  BMC Infect Dis       Date:  2016-12-19       Impact factor: 3.090

3.  Seroprevalence of Hepatitis B Virus and Associated Factors among Health Professionals in University of Gondar Hospital, Northwest Ethiopia.

Authors:  Aynishet Adane Gebremariam; Adino Tesfahun Tsegaye; Yalelet Fentaw Shiferaw; Mebratu Mitiku Reta; Alem Getaneh
Journal:  Adv Prev Med       Date:  2019-03-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.